Alpha 2-Heremans-Schmid glycoprotein gene polymorphism (rs4918) is associated with coronary artery calcification in

Shuqi Dai1, Yun Chen1, Da Shang1

  • 1Department of Nephrology, Huashan Hospital, Fudan University, Shanghai, China.

Insights

The AHSG gene polymorphism rs4918 is linked to coronary artery calcification (CAC) progression in peritoneal dialysis (PD) patients. This genetic variant influences serum fetuin-A levels, a key calcification inhibitor.

Area of Science:

  • Nephrology
  • Genetics
  • Cardiovascular Disease

Background:

  • Coronary artery calcification (CAC) is a severe complication in peritoneal dialysis (PD) patients.
  • Fetuin-A, a serum calcification inhibitor, is encoded by the alpha 2-Heremans-Schmid glycoprotein (AHSG) gene.

Purpose of the Study:

  • To investigate the association between AHSG gene polymorphism rs4918 and CAC in PD patients.
  • To examine the role of rs4918 in the progression of CAC among PD patients.

Main Methods:

  • Prospective study of 202 incident PD patients followed for 2 years.
  • CAC measurements at baseline and 2-year follow-up.
  • Analysis of AHSG gene polymorphism rs4918, serum fetuin-A, and clinical data using binary logistic regression.

Main Results:

  • Genotype GG of AHSG rs4918 was an independent risk factor for CAC (OR=2.153) and CAC progression (OR=2.482).
  • Serum fetuin-A levels showed a dose-dependent effect influenced by the number of G alleles in rs4918.

Conclusions:

  • AHSG gene polymorphism rs4918 impacts serum fetuin-A levels.
  • rs4918 is significantly associated with the presence and progression of CAC in PD patients.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
46
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
95
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
23
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
23
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.0K